Faculty Information - KIKUCHI Noriko

（Last updated : 2025-07-04 15:21:47）

KIKUCHI Noriko
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Cardiology

Position Assistant Professor

■ Published papers

1.	Case report	Invasive Diagnostic Procedure in Patient With Anomalous Aortic Origin of a Right Coronary Artery. 2025/02
2.	Other	Cardiogenic shock severity predicts bleeding events in patients with temporary mechanical circulatory support. 2024/12
3.	Original article	Increased Left Ventricular End-Diastolic Volume Index Is Associated With Increased Adverse Events After MitraClip Implantation. 2024/01/15
4.	Case report	Early recurrence of myocarditis with atrioventricular block while wearing a wearable cardioverterdefibrillator after fulminant myocarditis: A case report 2023/05
5.	Original article	Clinical Validation of a Neointima-Inducing Inflow Cannula in a Continuous Flow Left Ventricular Assist Device. 2023/03
6.	Original article	Stratification of Destination Therapy Candidates by J-HeartMate Risk Score Among Elderly Non-Responders to Cardiac Resynchronization Therapy. 2022/08/26
7.	Original article	Ventricular Assist Device-Induced Ventricular Septal Perforation. 2022/07/25
8.	Original article	Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates. 2022/04
9.	Case report	Acute myocardial infarction and sudden cardiac arrest caused by anomalous left coronary artery arising from the noncoronary cusp 2022/01/03
10.	Original article	Impact of anatomical position of the inflow cannula on stroke in patients with left ventricular assist devices 2022/01
11.	Case report	Use of Three-Dimensional Computed Tomography to Image Archived Fatty Tissue of Arrhythmogenic Cardiomyopathy 2021/09/24
12.	Case report	Characteristics of Left-Dominant Arrhythmogenic Cardiomyopathy 2021
13.	Case report	Heart transplant candidate with medical complexity in the era of prolonged left ventricular assist device support — A case report 2020/10/22
14.	Original article	Impact of age on clinical outcomes of antihypertensive therapy in patients with hypertension and coronary artery disease: A sub-analysis of the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease. 2020/05
15.	Case report	An Autopsy Case of Arrhythmogenic Right Ventricular Cardiomyopathy　- Radiological/Pathological Comparison. 2020/04
16.	Original article	Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. 2019/06
17.	Original article	Impact of left ventricular ejection function on blood pressure-lowering therapy in hypertensive patients with coronary artery disease. 2016/05
18.	Case report	Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis. 2016/04
19.	Original article	Long-Term Prognostic Role of the Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2016/02
20.	Other	Pitavastatin Prevents Atherosclerotic Plaque Development via Inhibition of TRAIL Expression on CD4 T Cells 2010
21.	Other	Prognostic Implications of Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Long Term Follow up at a Tertiary Hospital in Japan 2010
22.	Other	Role of PSGL-1 Expressing CD4 T Cells in Acute Coronary Syndrome 2010
Display 5 items
Display all(22)

■ Academic conference presentation

1.	Treatment Strategies for Atrial Fibrillation in Heart Failure Patients Deemed to be Candidates for Left Ventricular Assist Device （Speech） 2025/03/29
2.	D-dimer Levels Predict Mortality in Patients with Temporary Mechanical Circulatory Support （Poster notice，General） 2024/03/10
3.	Hub and Spoke Model of Cardiogenic Shock Patients: The Role of Hub Hospital （Speech） 2024/03/09
4.	The Possibility of Destination Therapy for Elderly Non-responder of Cardiac Resynchronization Therapy （Speech，General） 2021/03/29
5.	Clinical Features of Deteriorating Cardiogenic Shock Patients （Speech） 2021/03/28
6.	Characteristics of Advanced Heart Failure Patients Candidate to Ventricular Assist Devices as Destination Therapy （Speech，Panelist at Symposium/Workshop (Other)） 2021/03/26
7.	Factors Associated With Ejection Fraction Improvement Among Hospitalized Heart Failure Patients With Reduced Ejection Fraction （Poster notice，General） 2019/11/17
8.	A case of chronic thromboembolic pulmonary hypertension in systemic sclerosis （Poster notice，General） 2019/10/05
9.	A case with ischemic severe heart failure improved temporary after Autologous myoblast sheets transplantation therapy, but we could not save （Poster notice，General） 2019/10/04
10.	Changes of ejection fraction among hospitalized heart failure patients: From HIJ-HFII study （Poster notice，General） 2019/10/04
11.	Change in left ventricular ejection fraction and outcome in heart failure patients with mid-range ejection fraction: from the HIJ-HF prospective study （Poster notice，General） 2019/09/02
12.	Myocardial flow reserve using 13N ammonia PET for detection of cardiac allograft vasculopathy in heart transplant patients （Poster notice，General） 2019/09/02
13.	Incidence and Predictors of Long-term Renal Function Deterioration after Implantation of a Centrifugal, Continuous-flow Device for Bridge to Transplant （Speech，General） 2019/04/05
14.	Myocardial Flow Reserve Using 13N Ammonia PET for Detection of Cardiac Allograft Vasculopathy （Poster notice，General） 2019/04/03
15.	Usefulness of Wearable Cardioverter Defibrillator as a Bridge Therapy （Poster notice，General） 2019/03/31
16.	13N Ammonia PET Myocardial Flow Reserve for Detection of Cardiac Allograft Vasculopathy in Heart Transplant Patients （Speech，General） 2019/03/30
17.	Management of Ventricular Arrhythmias in Patients with Implanted Ventricular Assist Devices （Speech，General） 2019/03/30
18.	Prognostic Impact of Discharge Serum Chloride Levels in Heart Failure Patients: An Analysis of HIJ-HF II Multicenter Cohort Study （Poster notice，General） 2019/03/30
19.	Renal Function and the Prognostic Impact of Renin-angiotensin-aldosterone System Inhibitors for Heart Failure Patients: An Analysis of HIJ-HF II Study （Speech，General） 2019/03/29
20.	A new treatment option with ipragliflozin administered additionally in a caseinvolving stage D heart failure with diabetes （Speech，General） 2018/10/13
21.	Treatment strategy for Cpc-PH after surgery of mitral valve disease; Insights from a case report （Speech，General） 2018/10/13
22.	Cardiac Resynchronization Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia: Case Reports and Clinical Implications （Speech，General） 2018/10/11
23.	Impact of congestion in worsening renal failure after implantation of a centrifugal, continuous-flow left ventricular device （Speech，General） 2018/08/27
24.	Temporal trends in clinical characteristics, management of heart failure patients with mid-range ejection fraction in Japan: from the HIJ-HF studies （Poster notice，General） 2018/05/26
25.	Use of mineralocorticoid receptor antagonists in real-world patients with nonischemic heart failure and reduced ejection fraction: an analysis of HIJ-HF II study （Poster notice，General） 2018/05/26
26.	Long-Term Changes in Renal Function after Implantation of a Centrifugal-type, Continuous-flow Left Ventricular Assist Device （Speech，General） 2018/03/25
27.	Use of Mineralocorticoid Receptor Antagonists in Real-world Heart Failure Patients with Reduced Ejection Fraction: An Analysis of HIJ-HF II Study （Speech，General） 2018/03/25
28.	Heterozygous Familial Hypercholesterolemia: Insight into Polygenetic Abnormalities in Japanese Patients （Speech，General） 2018/03/24
29.	Importance of physiological pacing on right heart failure in a case with left ventricular noncompaction and left ventricular assist device （Speech，General） 2017/10/13
30.	Long-term changes in renal function in patients after implantation of a centrifugal-type, continuous-flow left ventricular assist device （Speech，Panelist at Symposium/Workshop (Applied)） 2017/10/13
31.	Effectiveness of sildenafil for right ventricular failure after left ventricular assisted device implantation: a case report （Speech，General） 2017/10/12
32.	Successful withdrawal of implantable left ventricular assist device in a case with major cerebrovascular complication （Poster notice，General） 2017/10/12
33.	Short-term prevalence of fatal ventricular arrhythmic events in patients with newly diagnosed reduced left ventricular ejection fraction （Poster notice，General） 2017/08/29
34.	Heart Team Approach for LVAD - Cooperation with Home Medical Care - （Speech，Panelist at Symposium/Workshop (Applied)） 2017/03/19
35.	Recovery of Left Ventricular Ejection Fraction and Ventricular Arrhythmias in Heart Failure Patients: Prospects of Wearable Cardioverter Defibrillator （Speech，Panelist at Symposium/Workshop (Applied)） 2017/03/19
36.	Adverse Effect of Underuse of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Therapy in Elderly Patients Hospitalized with Heart Failure （Poster notice，General） 2017/03/18
37.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Japanese Heart Failure Patients: From the HIJ-HF Cohort Study （Speech，General） 2017/03/18
38.	Prognostic Factors in Japanese Elderly Heart Failure with Preserved Ejection Fraction: From the HIJ-HF II Cohort Study （Speech，General） 2017/03/17
39.	Short-term Prevalence of Fatal Ventricular Arrhythmic Event in Patients with Newly-diagnosed Reduced Ejection Fraction （Poster notice，General） 2017/03/17
40.	Beta-blockers and Prognosis in Patients with Atrial Fibrillation and Heart Failure: From the HIJ-HF Cohort （Speech，Panelist at Symposium/Workshop (Applied)） 2016/10/09
41.	A Case of Dilated Cardiomyopathy Demonstrating Markedly Improvement from Deteriorated Renal Function by Challenging Catecholamine Infusion and Succeeding an Implantable-VAD （Poster notice，General） 2016/10/08
42.	Short-term Prevalence of Fatal Ventricular Arrhythmic Event in Patients with Newly-diagnosed Reduced Ejection Fraction （Poster notice，General） 2016/10/08
43.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Heart Failure with Preserved Ejection Fraction: From the HIJ-HF cohort study （Speech，General） 2016/10/07
44.	The prognostic and therapeutic target role of atrial tachyarrhytmia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia （Speech，Panelist at Symposium/Workshop (Applied)） 2016/07/16
45.	Prognostic Role of Atrial Tachyarrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasi （Poster notice，General） 2016/03/19
46.	The Combination Therapy of Corticosteroid and Mycophenolate Mofetil in a Case of Refractory Cardiac Sarcoidosis （Speech，General） 2015/10/22
47.	Prognostic Significance of Myocardial Fibrosis Detected by Magnetic Resonance Imaging in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy （Speech，General） 2015/04/26
48.	Atrial Arrhythmia is a Marker of Disease Progression in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia （Poster notice，General） 2015/04/24
49.	Clinical Phases Vary with Disease Stage in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia （Speech，General） 2015/04/24
50.	PSGL-1 expressing CD4 T cells in plaque instability （Speech，General） 2011/08
51.	Impact of Pulmonary Artery Pressure and Transpulmonary gradient on Long-term Outcome in Dilated Cardiomyopathy Patients with Pulmonary Hypertension （Poster notice，General） 2011/03/20
52.	Clinical Phases Vary with Time Course in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia （Speech，General） 2011/03/19
53.	Prognostic Implications of Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Long Term Follow Up at a Tertiary Hospital in Japan （Speech，General） 2011/03/19
54.	The Model for End-Stage Liver Disease Score as an Independent Predictor of Outcomes in Cardiac Resynchronization Therapy （Speech，General） 2011/03/18
55.	The role of PSGL-1-expressing CD4 T cells in perimenopausal women （General） 2010/07
Display 5 items
Display all(55)

■ Education

1.		Faculty of Medicine, Tokyo Women's Medical University, Graduated,
2.	Degree Acquisition	Tokyo Women's Medical University,